IP Library › Patent Application 10581367
Patent Application
App. No. 10/581,367

Pharmaceutical Preparation Containing Gabapentin

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/581,367
Abstract

A gabapentin granulate obtained by granulating gabapentin with PEG having a melting point comprised between 50 and 80° C. and pharmaceutical compositions containing it, are described.

Claims (24)

1 . A gabapentin granulate obtained by granulating gabapentin with PEG having a melting point comprised between 50 and 80° C.

2 . The granulate according to claim 1 , wherein the gabapentin is present in an amount higher than 80% by weight.

3 . A granulate according to claim 1 , wherein the gabapentin is present in quantities higher than 90% by weight.

4 . A granulate according to claim 1 , wherein the gabapentin is present in quantities equal to 98% by weight, the PEG being 2%.

5 . A gabapentin pharracutical composition under tablet form obtained by compressing a granulate according to claim 1 .

6 . A gabapentin pharmaceutical composition under capsule form obtained by filling-in a gelatine capsule with a granulate according to claim 1 .

7 . A gabapentin pharmaceutical composition under the tablet form obtained by compressing a granulate according to claim 1 and known additives useful for the preparation of tablets.

8 . A gabapentin pharmaceutical composition under tablet form according to claim 7 , wherein the additives are chosen among diluents, lubricants, disgregants and glydants.

9 . A gabapentin pharmaceutical composition under tablet form according to claim 7 , wherein the additives represent between 0 and 30% by weight and preferably between 0 and 20% by weight of the tablet, the remaining to 100% being a granulate of claim 1 .

10 . A gabapcntin pharmaceutical composition under capsule form obtained by filling-in a gelatine capsule with a granulate according to claim 1 and known additives useful for the preparation of pharmaceutical forms in capsule.

11 . A gabapentin pharmaceutical composition under the capsule form according to claim 10 , wherein the additives represent between 0 and 30% by weight and preferably between 0 and 20% by weight of the capsule content, the remaining to 100% being a granulate of claim 1 .

12 . A gabapentin granulate obtained by granulating gabapentin with PEG having a melting point comprised between 50 and 80° C. and additives known for the preparation of solid pharmaceutical forms chosen among tablets and capsules.

13 . A gabapentin granulate obtained by granulating gabapentin according to claim 12 , wherein the additives are chosen among diluents, lubricants, disgregants and glydants.

14 . A granulate according to claim 12 having the following composition:

gabapentin

80-98% by weight 

PEG

2-25% by weight

additives

0-20% by weight

15 . A gabapentin pharmaceutical composition under tablet form obtained by compressing a granulate according to claim 12 .

16 . A gabapentin pharmaceutical composition under capsule form obtained by filling-in a gelatine capsule with a granulate according to claim 12 .

17 . A gabapentin chemical composition under tablet or capsule form containing a granulate according to claim 1 .

18 . A gabapentin chemical composition under tablet or capsule form containing a granulate according to claim 12 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2007
From: ZAMBON GROUP S.P.A.
To: ZAMBON S.P.A.
Reel/Frame 019640/0959 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2007
From: RAMPOLDI, LUCA; GRASSANO, ALESSANDRO
To: ZAMBON GROUP S.P.A.
Reel/Frame 019503/0096 →